AstraZeneca Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Quarter	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Sep '25 Sep 30, 2025	Jun '25 Jun 30, 2025	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Sep '24 Sep 30, 2024	Jun '24 Jun 30, 2024	Mar '24 Mar 31, 2024	Dec '23 Dec 31, 2023	Sep '23 Sep 30, 2023	Jun '23 Jun 30, 2023	Mar '23 Mar 31, 2023	Dec '22 Dec 31, 2022	Sep '22 Sep 30, 2022	Jun '22 Jun 30, 2022	Mar '22 Mar 31, 2022	Dec '21 Dec 31, 2021	Sep '21 Sep 30, 2021
Cash & Equivalents	4,893	7,560	5,711	8,143	7,058	5,230	5,488	4,797	6,916	7,841	5,840	4,871	5,664	6,232	6,166	4,458	4,817	5,762	6,329	7,067
Short-Term Investments	75	115	30	39	50	165	166	133	160	180	122	244	148	230	239	440	70	61	69	82
Cash & Short-Term Investments	4,968	7,675	5,741	8,182	7,108	5,395	5,654	4,930	7,076	8,021	5,962	5,115	5,812	6,462	6,405	4,898	4,887	5,823	6,398	7,149
Cash Growth (YoY)	-30.11%	42.26%	1.54%	65.96%	0.45%	-32.74%	-5.17%	-3.62%	21.75%	24.13%	-6.92%	4.43%	18.93%	10.97%	0.11%	-31.49%	-68.73%	-25.01%	-19.95%	-15.36%
Accounts Receivable	14,330	14,106	15,177	14,338	14,168	13,250	12,972	11,879	11,047	11,072	12,126	11,300	11,092	10,289	10,521	9,336	8,908	8,683	9,644	8,258
Inventory	6,932	6,570	6,557	6,593	6,467	5,884	5,288	5,662	5,667	5,337	5,424	5,292	5,051	4,967	4,699	5,078	6,220	7,624	8,983	10,528
Other Current Assets	1,735	1,262	1,248	827	1,196	1,610	1,913	1,684	1,603	1,164	1,542	794	884	548	968	912	902	517	1,219	756
Total Current Assets	27,965	29,613	28,723	29,940	28,939	26,139	25,827	24,155	25,393	25,594	25,054	22,501	22,839	22,266	22,593	20,224	20,917	22,647	26,244	26,691
Net Property, Plant & Equipment	16,300	14,941	14,703	13,783	13,229	12,303	11,647	11,513	10,833	10,616	10,502	9,700	9,624	9,599	9,449	9,227	9,627	10,015	10,171	10,162
Other Intangible Assets	37,723	36,908	37,846	38,191	37,925	37,550	37,177	39,394	39,426	38,834	38,089	37,687	38,326	39,291	39,307	39,585	39,900	41,265	42,387	44,104
Goodwill	21,181	21,194	21,242	21,219	21,222	21,130	21,025	21,139	21,060	19,978	20,048	19,939	19,960	20,001	19,820	19,707	19,821	19,963	19,997	20,081
Long-Term Investments	2,916	2,665	2,525	2,286	2,139	1,900	1,900	2,145	1,871	1,695	1,677	1,290	1,143	1,234	1,142	1,102	1,180	1,237	1,237	1,585
Other Long-Term Assets	9,748	8,694	9,035	9,037	8,968	7,231	6,459	6,576	5,757	5,576	5,749	4,969	4,651	4,296	4,172	4,340	5,134	5,146	5,327	4,598
Total Assets	115,833	114,015	114,074	114,456	112,422	106,253	104,035	104,922	104,340	102,293	101,119	96,086	96,543	96,687	96,483	94,185	96,579	100,273	105,363	107,221
Accounts Payable	22,893	22,505	25,280	25,028	23,986	22,544	22,465	21,684	20,463	19,699	22,374	20,542	19,738	19,210	19,040	17,694	17,821	17,864	18,938	18,663
Current Portion of Long-Term Debt	5,808	7,576	3,104	6,174	6,492	3,403	2,337	1,253	5,067	6,050	5,129	5,372	4,556	3,625	5,314	5,408	2,162	2,069	1,660	2,744
Current Portion of Leases	426	383	382	379	361	355	339	317	292	281	271	235	231	232	228	210	220	225	233	229
Other Current Liabilities	2,426	2,106	1,851	2,473	2,697	2,827	2,725	2,672	2,744	2,871	2,768	2,439	1,850	1,793	1,711	1,538	1,612	2,582	1,763	2,013
Total Current Liabilities	31,553	32,570	30,617	34,054	33,536	29,129	27,866	25,926	28,566	28,901	30,542	28,588	26,375	24,860	26,293	24,850	21,815	22,740	22,594	23,649
Long-Term Debt	23,683	24,454	24,715	24,700	24,714	26,692	26,506	28,887	27,225	27,259	22,365	22,225	24,329	26,916	22,965	23,013	26,461	28,081	28,134	28,206
Long-Term Leases	2,322	1,505	1,421	1,379	1,272	1,196	1,113	1,105	949	961	857	744	722	730	725	668	685	724	754	733
Other Long-Term Liabilities	7,905	8,102	8,602	8,352	8,090	8,105	7,679	8,199	8,002	7,671	8,189	7,308	7,701	8,370	9,442	10,500	11,667	12,369	14,594	14,721
Total Long-Term Liabilities	33,910	34,061	34,738	34,431	34,076	35,993	35,298	38,191	36,176	35,891	31,411	30,277	32,752	36,016	33,132	34,181	38,813	41,174	43,482	43,660
Total Liabilities	65,463	66,631	65,355	68,485	67,612	65,122	63,164	64,117	64,742	64,792	61,953	58,865	59,127	60,876	59,425	59,031	60,628	63,914	66,076	67,309
Common Stock	388	388	388	388	388	388	388	388	388	388	388	387	387	387	387	387	387	387	387	387
Additional Paid-in Capital	37,315	37,273	35,867	35,243	37,308	37,287	35,827	35,203	35,199	35,194	35,789	35,166	35,163	35,159	35,756	35,137	35,134	35,131	35,727	35,118
Accumulated Other Comprehensive Income	-	-	1,440	2,044	-	-	1,411	1,990	2,078	2,075	1,464	2,078	2,076	2,068	1,468	2,081	2,068	2,050	1,444	2,039
Retained Earnings	12,592	9,672	10,972	8,213	7,023	3,364	3,160	3,138	1,847	-212	1,502	-434	-234	-1,825	-574	-2,471	-1,657	-1,228	1,710	2,200
Total Common Shareholders' Equity	50,295	47,333	48,667	45,888	44,719	41,039	40,786	40,719	39,512	37,445	39,143	37,197	37,392	35,789	37,037	35,134	35,932	36,340	39,268	39,744
Minority Interest	75	51	52	83	91	92	85	86	86	56	23	24	24	22	21	20	19	19	19	168
Shareholders' Equity	50,370	47,384	48,719	45,971	44,810	41,131	40,871	40,805	39,598	37,501	39,166	37,221	37,416	35,811	37,058	35,154	35,951	36,359	39,287	39,912
Total Liabilities & Equity	115,833	114,015	114,074	114,456	112,422	106,253	104,035	104,922	104,340	102,293	101,119	96,086	96,543	96,687	96,483	94,185	96,579	100,273	105,363	107,221
Total Debt	32,239	33,918	29,622	32,632	32,839	31,646	30,295	31,562	33,533	34,551	28,622	28,576	29,838	31,503	29,232	29,299	29,528	31,099	30,781	31,912
Net Cash (Debt)	-27,271	-26,243	-23,881	-24,450	-25,731	-26,251	-24,641	-26,632	-26,457	-26,530	-22,660	-23,461	-24,026	-25,041	-22,827	-24,401	-24,641	-25,276	-24,383	-24,763
Net Cash Growth (YoY)	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Cash Per Share	-17.48	-16.81	-15.28	-15.66	-16.50	-16.82	-15.78	-17.05	-16.96	-17.01	-14.52	-15.04	-15.40	-16.05	-14.64	-15.65	-15.80	-16.19	-15.76	-16.55
Book Value	50,295	47,333	48,667	45,888	44,719	41,039	40,786	40,719	39,512	37,445	39,143	37,197	37,392	35,789	37,037	35,134	35,932	36,340	39,268	39,744
Book Value Per Share	32.24	30.32	31.14	29.40	28.68	26.29	26.11	26.07	25.33	24.00	25.08	23.84	23.97	22.94	23.76	22.54	23.03	23.28	25.38	26.57
Tangible Book Value	-8,609	-10,769	-10,421	-13,522	-14,428	-17,641	-17,416	-19,814	-20,974	-21,367	-18,994	-20,429	-20,894	-23,503	-22,090	-24,158	-23,789	-24,888	-23,116	-24,441
Tangible Book Value Per Share	-5.52	-6.90	-6.67	-8.66	-9.25	-11.30	-11.15	-12.69	-13.44	-13.70	-12.17	-13.10	-13.39	-15.07	-14.17	-15.50	-15.25	-15.94	-14.94	-16.34

SEC Filings: 10-K · 10-Q